Drug profile · INN
ambrisentan
AMBRISENTAN ZENTIVA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ambrisentan (AMBRISENTAN ZENTIVA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN ambrisentan
Brand AMBRISENTAN ZENTIVA
Route ORAL
Formulation TABLET
ATC code C02KX02
Frequently asked questions
What is ambrisentan?
ambrisentan (AMBRISENTAN ZENTIVA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ambrisentan?
AMBRISENTAN ZENTIVA is a marketed brand name for ambrisentan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ambrisentan?
ambrisentan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.